Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer
Clinical trial NCT02718820 · COMPLETED
Trial details
- NCT number
- NCT02718820
- Sponsor
- Medical University of Vienna
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2021-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.